0000000000799707

AUTHOR

Joanna Streb

showing 5 related works from this author

Factors Affecting Sexual Function and Body Image of Early-Stage Breast Cancer Survivors in Poland: A Short-Term Observation

2019

Abstract Introduction Knowing the important factors influencing sexual function and body image might facilitate the recovery process of breast cancer survivors. Surgery type, relationship quality, and partner support might be modified to create a space for psychosexual intervention. Patients and Methods This retrospective questionnaire-based study was performed on 128 women aged 18 to 65 years who were free of disease at time of study entry and who underwent surgical treatment for breast cancer. Diagnostic and Statistical Manual of Mental Disorders criteria were used to assessed female sexual dysfunction (FSD). Changes in Sexual Functioning Questionnaire (CSFQ) were used to measure sexual f…

0301 basic medicineAdultCancer Researchmedicine.medical_specialtyAdolescentbody imagebreast cancer survivorsmedicine.medical_treatmentMammaplastySexual BehaviorFemale sexual dysfunctionBreast NeoplasmsMastectomy Segmental03 medical and health sciencesYoung Adultdeterminant factors0302 clinical medicineBreast cancersurgery timeQuality of lifeCancer SurvivorsInternal medicineMedicineHumansMastectomyAgedRetrospective Studiesbusiness.industryOdds ratioMiddle Agedmedicine.disease030104 developmental biologySexual dysfunctionOncologysexual dysfunction030220 oncology & carcinogenesisQuality of LifeAnxietyFemalePolandmedicine.symptombusinessSexual functionMastectomyClinical Breast Cancer
researchProduct

Breast-conserving surgeries in HER-positive breast cancer patients are performed too rarely in Poland

2020

Breast cancer is the most common cancer among women in Poland and worldwide; after lung cancer it is the second highest cause of death among females with malignancies. HER2 positive breast cancer occurs in ca.15–20% of all cases. More often than other subtypes, it affects younger patients and more often spreads metastasises to internal organs. The new drugs against the HER2 receptor significantly improve patients’ prognoses, regardless of the initial stage. The authors of the study involved 1503 patients with HER2 positive breast cancer from all stages (I–IV); 482 patients received preoperative systemic therapy (chemotherapy or hormonal therapy), 385 trastuzumab. Among the 1219 females qual…

OncologyCancer Researchmedicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentCancermedicine.diseaseBreast cancerOncologyTrastuzumabInternal medicineMedicineHormonal therapybreast cancer; HER2 positive breast cancer; surgery; mastectomy; breast conserving therapyskin and connective tissue diseasesbusinessLung cancerMastectomymedicine.drugCause of deathNowotwory Journal of Oncology
researchProduct

Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic : comprehensive recommendations of the Polish Society of C…

2020

Clinical Oncologymedicine.medical_specialtyOncologyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicmedicineIntensive care medicinebusiness
researchProduct

P-57 Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland

2020

OncologyClinical Practicemedicine.medical_specialtyOncologyColorectal cancerbusiness.industryInternal medicinemedicineIn patientHematologymedicine.diseasebusinessAnnals of Oncology
researchProduct

Adjuvant chemotherapy for early-stage breast cancer patients — daily clinical practice in selected cancer centres in Poland

2017

Background. Adjuvant chemotherapy for high-risk early-stage breast cancer patients significantly improves long-term treatment results. The decision to administer chemotherapy is made based primarily on prognostic factors (defined by the pathological characteristics of the primary tumour and regional lymph nodes) and also on patient-related factors, such as age, menopausal status and comorbidities. The guidelines on adjuvant chemotherapy have been established and reviewed for many years by several medical societies (NCCN, ESMO, PTOK, PUO) and experts of St. Gallen International Breast Cancer Conference. The aim of this study was to assess the pattern of adjuvant chemotherapy administration t…

OncologyCancer Researchmedicine.medical_specialtyChemotherapyAnthracyclinebusiness.industrymedicine.medical_treatmentCancermedicine.diseaseBreast cancerOncologyTrastuzumabInternal medicinemedicineStage (cooking)businessAdjuvantPathologicalmedicine.drugNowotwory. Journal of Oncology
researchProduct